BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
Commitment to contribute to the greater good.
Qu’est-ce qui vous rend le plus heureux au travail?
Ability to drive change and make an impact
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Strong alignment with BlueRock 's values; Authenticity in planning, communication and relationships A diverse, multi-faceted team - that promotes inclusivity.
Quelles sont les meilleures choses à propos de votre équipe?
My team is competent, intelligent and super-hard workers and still they manage to be super-friendly at ALL times! Very personable, genuine and helpful.
Other Employee Reviews for BlueRock Therapeutics
×